Diversity Isn't Always The Key

CEO William Stavropoulos explains why Dow stayed with chemicals

Seven years ago, Dow Chemical Co.'s top executives took a long, hard look at the business and did something unusual: They decided to keep the company focused on chemicals. It was a contrarian move in a decade when rivals from Monsanto Co. to Germany's Hoechst were pulling out of chemicals and getting into higher-margin sectors, such as drugs and agricultural biotech.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.